Hide metadata

dc.date.accessioned2023-01-17T16:34:09Z
dc.date.available2023-01-17T16:34:09Z
dc.date.created2022-05-23T14:38:22Z
dc.date.issued2022
dc.identifier.citationDas, Mrinal Kumar Haugen, Øyvind Pernell Haugen, Trine B. . Diverse Roles and Targets of miRNA in the Pathogenesis of Testicular Germ Cell Tumour. Cancers. 2022, 14(5), 1-11
dc.identifier.urihttp://hdl.handle.net/10852/98869
dc.description.abstractTesticular germ cell tumour (TGCT) is the most common cancer type among young adults in many parts of the world. Although the pathogenesis of TGCT is not well understood, the involvement of heritable components is evident, and the risk is polygenic. Genome-wide association studies have so far found 78 susceptibility loci for TGCT, and many of the loci are in non-coding regions indicating the involvement of non-coding RNAs in TGCT pathogenesis. MicroRNAs (miRNAs), a class of non-coding RNAs, have emerged as important gene regulators at the post-transcriptional level. They are crucial in controlling many cellular processes, such as proliferation, differentiation, and apoptosis, and an aberrant miRNA expression may contribute to the pathogenesis of several cancers, including TGCT. In support of this notion, several studies reported differential expression of miRNAs in TGCTs. We previously demonstrated that miRNAs were the most common group of small non-coding RNAs in TGCTs, and several functional studies of miRNAs in TGCTs suggest that they may act as either oncogene or tumour suppressors. Moreover, individual miRNA targets and downstream pathways in the context of TGCT development have been explored. In this review, we will focus on the diverse roles and targets of miRNAs in TGCT pathogenesis.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleDiverse Roles and Targets of miRNA in the Pathogenesis of Testicular Germ Cell Tumour
dc.title.alternativeENEngelskEnglishDiverse Roles and Targets of miRNA in the Pathogenesis of Testicular Germ Cell Tumour
dc.typeJournal article
dc.creator.authorDas, Mrinal Kumar
dc.creator.authorHaugen, Øyvind Pernell
dc.creator.authorHaugen, Trine B.
cristin.unitcode185,51,12,0
cristin.unitnameAvdeling for molekylærmedisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin2026612
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Cancers&rft.volume=14&rft.spage=1&rft.date=2022
dc.identifier.jtitleCancers
dc.identifier.volume14
dc.identifier.issue5
dc.identifier.doihttps://doi.org/10.3390/cancers14051190
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2072-6694
dc.type.versionPublishedVersion
cristin.articleid1190


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International